Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 217Thoracic 49Breast 37Head & Neck 28Gynecologic 20Dermatologic 19Sarcoma 15Genitourinary 15CNS 11Other hematologic neoplasm 7Endocrine 7NET 5Plasma cell 4Lymphoid 2Classical hematology 2Other solid neoplasm 1Myeloid 1

Conditions

Advanced Solid Tumors 173Advanced Solid Tumor 150Solid Tumor 129Mesothelioma 88Mesothelioma, Malignant 81Solid Tumors 79Hematopoietic and Lymphatic System Neoplasm 47Solid Tumor, Adult 35Carcinoma, Non-Small-Cell Lung 32Retinoblastoma 29Ovarian Neoplasms 26Melanoma 24Colorectal Neoplasms 22Pancreatic Neoplasms 21Stomach Neoplasms 20Sarcoma 20Lung Neoplasms 19Carcinoma, Renal Cell 18Uterine Cervical Neoplasms 16Esophageal Neoplasms 16Neoplasms 15Malignant Solid Neoplasm 15Neoplasm Metastasis 14Hematopoietic and Lymphoid System Neoplasm 14Advanced or Metastatic Solid Tumors 14Triple Negative Breast Neoplasms 13Solid Tumor Malignancies 13Small Cell Lung Carcinoma 13Advanced Malignant Solid Tumor 13Urinary Bladder Neoplasms 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Other solid neoplasm × 1 year × Clear all
NCT03834272 2026-01-16

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Lumicell, Inc.

Phase 1/2 Completed
18 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Gastrointestinal Neoplasms, Mesothelioma, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡